The appointment, confirmed on 23 June, comes as Starling continues to navigate falling profitability, a dominant shareholder with divergent strategic preferences, and a UK fintech IPO pipeline that remains stubbornly thin. For any scale-up approaching public markets, the composition of Starling's board tells a more instructive story than the appointment itself.

Who is Colin Bell and what does he bring?

Colin Bell served as chief executive of HSBC Bank, the UK ring-fenced subsidiary of HSBC Holdings (LSE: HSBA), before stepping down. He joined Starling's board as a non-executive director in November 2025, according to the company, giving him roughly seven months of familiarity with the business before assuming the chair.

His background is rooted in institutional banking, compliance, and regulatory engagement, areas where digital challengers have historically been lighter. The selection of a figure with deep experience inside a systemically important bank suggests Starling is prioritising credibility with regulators and institutional investors over fintech-native governance.

Starling described the changes to its board as being "in ordinary course of business" and said it had "already strengthened" the body with the appointment of former Hargreaves Lansdown chief executive Dan Olley, as reported by City AM. The framing is deliberate: the bank wants the transition to read as planned succession rather than crisis management.

But the scale and speed of the turnover invite scrutiny.

A board in transition: who has left and why it matters

Bell replaces David Sproul as chair. Sproul's departure is accompanied by that of Tracy Clarke, who led the search for his successor and is also set to leave, according to Starling's most recent annual report.

Two further directors have already gone. Marcus Traill, who is connected to billionaire investor Harald McPike, departed earlier in June, as reported by City AM. Richard Watts, a fund manager at Chrysalis Investments, one of Starling's backers, also left the board.

More departures are expected in the coming months, according to Bloomberg, with Starling not planning to replace those who have already exited. That means the board is being deliberately slimmed, not merely refreshed.

The departure of Traill is particularly significant. McPike, a Bahamas-based billionaire, provided a crucial $70m investment in Starling in 2016 during the bank's infancy. He retains a stake of approximately one-third of the company, according to Companies House filings from February 2025, as City AM reported. Losing his representative on the board raises questions about the degree of alignment between Starling's largest shareholder and its executive leadership.

City AM revealed earlier in 2026 that McPike had withdrawn support for a London IPO. Sources close to McPike indicated he was under the impression Starling was warming to a US listing, a move he had previously pushed back against, creating a strategic impasse.

The exit of Watts, meanwhile, removes a voice linked to one of Starling's financial investors. Together, these departures strip the board of its most explicit shareholder-representative directors, concentrating authority among executives and independent non-executives. That is a common pre-IPO governance pattern, but it also reduces the channels through which major investors can influence strategy before a listing locks in new structures.

The listing question: London, New York, or neither?

Starling's IPO has been discussed for years. The tone from the company's leadership has shifted markedly over that period.

Former interim chief executive John Mountain previously described the City as a "natural home" for Starling, saying the fintech was "very committed" to a London listing, as reported by City AM. That position has since softened considerably.

Finance director Declan Ferguson said last summer that there was no "concrete view" on where the neobank would list and that any decision was still "in flux", as City AM reported. Chief executive Raman Bhatia, in an interview with the Sunday Times in January 2026, said he was "non-committal" over a listing venue and that an IPO was not expected in the short term.

"Ultimately it's a decision for shareholders, so we have not concluded on that," Bhatia told the Sunday Times.

The shift from "very committed" to London to "non-committal" on venue is notable. It reflects both the gravitational pull of US capital markets for high-growth technology companies and the specific dynamics of Starling's shareholder register, where McPike's preferences carry substantial weight given his approximate one-third holding.

Starling is not alone in deferring. The UK fintech IPO pipeline remains thin. Monzo and Revolut have both delayed or deferred listing plans. Klarna's US IPO, while it did proceed, has offered a cautionary reference point for challenger-bank and fintech valuations more broadly.

For the City, the unresolved question of where Starling lists carries symbolic weight. London has struggled to attract high-growth technology floats in recent years, and losing a homegrown digital bank to New York would reinforce the narrative that the UK market cannot compete for its own success stories.

Starling's most recent annual results showed a slide in profit as falling interest rates compressed net interest income, the primary revenue line for a deposit-funded lender. That financial trajectory complicates the IPO calculus: listing into a period of declining profitability demands either a compelling growth narrative or patience to wait for a more favourable cycle.

What scale-ups can learn from Starling's governance reset

Starling's boardroom overhaul illustrates a pattern familiar to any business moving from founder-era governance to institutional-grade oversight.

The first phase of a high-growth company's board is typically shaped by the investors who funded its early rounds. Directors are often representatives of major shareholders or connected to the founding team. That structure works when the priority is speed, product development, and fundraising.

The second phase, which Starling is now entering, requires a board built for public-market scrutiny: independent directors with relevant sector experience, audit and risk committee chairs with listed-company credentials, and a chair who can manage the relationship between executives, shareholders, and regulators.

Bell's appointment fits that template. But the transition is rarely smooth, and Starling's experience highlights three tensions that recur across the scale-up landscape.

Shareholder alignment before listing

A dominant shareholder with a different strategic vision, whether on listing venue, timing, or valuation expectations, can stall an IPO indefinitely. Starling's board has lost its most direct links to McPike's interests at precisely the moment those interests appear to diverge from management's direction. How that tension resolves will determine whether the IPO proceeds at all.

Board size and composition

Slimming a board before a listing can signal discipline, but it also concentrates decision-making. Starling's choice not to replace departing directors suggests confidence in the remaining group, but public-market investors and proxy advisers will scrutinise whether the board has sufficient independence and diversity of expertise.

Tone management

The shift from "very committed" to a London listing to "non-committal" on venue, delivered across three different spokespeople over roughly 18 months, risks appearing indecisive. Scale-ups approaching a listing benefit from consistency in external messaging, even if internal deliberations remain fluid.

Starling's governance reset is not unusual for a company at its stage. What makes it instructive is the visibility of the tensions driving it: a dominant shareholder, a changing interest-rate environment, and a listing market that has yet to reopen convincingly for UK fintechs. The board Bell inherits will need to resolve all three before any IPO prospectus is drafted.